# A Single Dose, 4-Period, 2-Treatment Replicate Design Bioequivalency Study of Granisetron Hydrochloride 1 mg Tablets Under Fasting Conditions

> **NCT00618254** · NA · COMPLETED · sponsor: **Roxane Laboratories** · enrollment: 32 (actual)

## Conditions studied

- Nausea
- Vomiting

## Interventions

- **DRUG:** Granisetron

## Key facts

- **NCT ID:** NCT00618254
- **Lead sponsor:** Roxane Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2005-04
- **Final completion:** 2005-04
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2018-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00618254

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00618254, "A Single Dose, 4-Period, 2-Treatment Replicate Design Bioequivalency Study of Granisetron Hydrochloride 1 mg Tablets Under Fasting Conditions". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT00618254. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*